Request for Information: Advanced Tissue-engineered Human Ectypal Networks Analyzer (ATHENA)
LANS is opening this Request for Information to gauge interest in engaging as an industry partnerwith LANS for collaboration in advancing a next-gen in vitro platform for lead compound and toxicity screening.
Submit your response by email to email@example.com by 11:59 PM MST on Friday, May 27, 2016.
Background and Technology Description
Over the past 3+ years, Los Alamos scientists have developed a milli-scale surrogate human organ bioreactor, coupled with highly sensitive analytical technologies. Dubbed the Advanced Tissue-engineered Human Ectypal Networks Analyzer (ATHENA), the platform is a human organ construct developed for screening of lead compounds, testing of medical countermeasures, and toxicity testing.
Periodically the Laboratory notifies the public of technologies and capabilities that may be of interest. These technologies may extend from recent inventions, technology opportunity or capabilities that may have utility outside the Laboratory. If you are interested in any of the following LANS capabilities, please contact the Business Development Team.
- Cancer genomics analytic capability
- Taste-based real-time point-of-care diagnostics for common respiratory diseases
- Nucleic acid-based and -inspired materials, functional systems, detection and screening techniques
- LIBS for Sustainable Agriculture
- Nitrogen-Rich Macrocyclic Ligands, Chelation Complexes Thereof, and Process for Selective Chelation of Radioactive Bismuth Ions with the Ligands
- Biohybrid Electro-Optical Neural Interface
- Novel Drug Development Approach
- Multifunctional Cell Imaging Polymers
- Multifunctional Non-Blinking Nanoshells for Therapy
- Luminescent Solar Concentrators
- Rapid Encapsulation of Biomolecules in Sol-Gel Using Microwave
- Pathogen Detection with RNA Sequencing
- Method for Nondestructive Inspection Using Continuous Ultrasonic Wave Generation
- Ultra-Low Field Nuclear Magnetic Resonance
- Detection of Explosives Concealed on or Within the Body Using Combined Ultra-Low Field NMR and NQR
- 3D Stereoscopic Radiography